Skip to main content
. Author manuscript; available in PMC: 2024 May 15.
Published in final edited form as: Circulation. 2023 Nov 30;149(1):e1–e156. doi: 10.1161/CIR.0000000000001193

Recommendations for AF Complicating ACS or PCI

Referenced studies that support the recommendations are summarized in the Online Data Supplement.

COR LOE Recommendations
1 A 1. In patients with AF and an increased risk for stroke who undergo PCI, DOACs are preferred over VKAs in combination with APT to reduce the risk of clinically relevant bleeding.15
1 A 2. In most patients with AF who take oral anticoagulation and undergo PCI, early discontinuation of aspirin (1–4 wk) and continuation of dual antithrombotic therapy with OAC and a P2Y12 inhibitor is preferred over triple therapy (OAC, P2Y12 inhibitor, and aspirin) to reduce the risk of clinically relevant bleeding.14,6